Allakos' Series A - II Round

Allakos raised a round of funding on September 30, 2014.

Allakos is a product-focused biotechnology company developing antibody-based therapeutics to treat diseases in which the dysregulation of the T-helper type 2 (Th2) immune response plays a key role in …

Articles about Allakos' Series A - II Round: